Subject: New Client RXMD Looks to Finish 2017 Strong on with Excellent November Sales Figures

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
New Client RXMD Looks to Finish 2017 Strong on with Excellent November Sales Figures
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.0155

Change (%): + 0.0009 (6.21)

Volume: 264,777
RXMD Chart

Progressive Care Reports Strong November Sales to Begin End of Year Rally

MIAMI, Dec. 15, 2017 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces over $1.7 million in net revenues on nearly 21,000 prescriptions filled in November 2017.

PharmCo, LLC filled just under 21,000 prescriptions during the month of November, generating approximately 1.7 million in net revenues. Prescriptions filled increased by nearly 13% over the same month last year. The company also filled over $400,000 worth of prescriptions for 340B entities, generating fees to the pharmacy of just over $17,000. PharmCo has achieved much of its growth through targeted marketing to new doctor’s offices and clinics.

The pharmacy is expecting to achieve increased growth through the remainder of the year, with momentum propelling the company into the New Year. This is based on feedback from current and prospective health care providers looking to improve their performance rating with insurance carriers. Medicare and commercial insurance companies are elevating the performance requirements that all providers must adhere to in order to achieve bonuses. Adherence to medication therapies are a significant portion of these performance measures, which necessitates relationships with pharmacies who have high performance ratings in adherence and medication therapy management (MTM).

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks